Loann Kim Do, OTR Occupational Therapist - Neurorehabilitation Medicare: Not Enrolled in Medicare Practice Location: 579 Auto Center Dr, Watsonville, CA 95076 Phone: 831-722-9680 Fax: 831-724-9311 |
Ashley Suzanne Preto, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 919 Freedom Blvd, Watsonville, CA 95076 Phone: 831-722-3581 |
Emiko Kanzawa Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 919 Freedom Blvd, Watsonville, CA 95076 Phone: 831-722-3581 |
Mrs. Barbara Lynne Graham-garcia, OTR/L, CHT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 579 Auto Center Dr, Watsonville, CA 95076 Phone: 831-722-9680 Fax: 831-724-9311 |
Nancy M. Washwell, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 140 Herman Ave, Watsonville, CA 95076 Phone: 805-821-1585 |
The Hand Therapy Specialists Occupational Therapist Medicare: Medicare Enrolled Practice Location: 240 Westgate Dr Ste 232, Watsonville, CA 95076 Phone: 831-531-8277 Fax: 831-576-7717 |
Pamela Wolfe, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 394 S Green Valley Rd, Watsonville, CA 95076 Phone: 831-786-9000 |
Kathleen Wood Appenrodt, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 579 Auto Center Dr, Watsonville, CA 95076 Phone: 831-722-9680 |
Paulino Navarro Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 585 Creek Dr, Watsonville, CA 95076 Phone: 831-512-4883 |
Pamela Nail Occupational Therapist - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 6 Hangar Way, Suite A, Watsonville, CA 95076 Phone: 831-786-0600 |
Mary Claire Claire Hood, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 525 Auto Center Dr, Watsonville, CA 95076 Phone: 205-270-9588 |
News Archive
Academic Medical Centers must adjust and adapt to the new health care reform laws or risk marginalization in the new health care arena, according to a New England Journal of Medicine Perspective article published online February 2.
The Charité - Medical University of Berlin has today begun the implementation of the clinical study phase I/II with the renal cancer medication MGN1601 (ASET Study). With this MOLOGEN AG product, an innovative cell-based gene therapy for the treatment of advanced renal cancer is entering the first important test phase.
With an accuracy rating of 98 percent, specially-trained dogs were able to smell volatile organic compounds (VOCs) released into urine by prostate tumors, setting the stage for a potentially new means of early prostate cancer detection.
Using two-dimensional barcodes on vaccine product labels would enhance the safety of the U.S. immunization system and save more than $300 million by 2023, according to a study by researchers at RTI International and the U.S. Centers for Disease Control & Prevention.
› Verified 6 days ago